Tenax Therapeutics Inc. (NASDAQ:TENX) traded with a subtraction of -$0.01 to $0.39 on Thursday, a downside of -3.77 percent. An average of 1,272,780 shares of common stock have been traded in the last five days. There was a gain of $0.0527 in the past week, and it reached a new high 2 times over the past 12 months. The last 20 days have seen an average of 913,750 shares traded, while the 50-day average volume stands at 695,170.
TENX stock has increased by 20.73% in the last month. The company shares reached their 1-month lowest point of $0.2841 on 08/08/23. With the stock rallying to its 52-week high on 02/02/23, shares of the company touched a low of $0.25 and a high of $7.40 in 52 weeks. It has reached a new high 7 times so far this year and lost -82.72% or -$1.8453 in price. In spite of this, the price is down -94.79% from the 52-week high.
Valuation Metrics
Tenax Therapeutics Inc. (TENXstock’s beta is 2.00. Other valuation ratios to consider include the price-to-book (PB) ratio at 0.64.
Financial Health
The quick ratio of Tenax Therapeutics Inc. for the three months ended June 29 was 17.00, and the current ratio was 17.00, indicating that the company is able to meet its debt obligations. Further, the company has a long term debt to equity ratio of 0.00 and a total debt to equity ratio of 0.02 for the quarter ending June 29. Its gross profit as reported stood at $4000.0 compared to revenue of $11.06 million.
Earnings Surprise
In the quarter under review, the net income was down than the previous quarter. The company posted a net income of $1.11 million in the quarter, while revenues of $1.41 million were shrunk -157.66%. The analyst consensus anticipated Tenax Therapeutics Inc.’s latest quarter earnings to come in at -$0.1 per share, but it turned out to be -$0.05, a 50.00% surprise. For the quarter, EBITDA amounted to -$1.24 million. Shareholders own equity worth $23.86 million.
Technical Picture
From a technical analysis perspective, let’s take a brief look at Tenax Therapeutics Inc. (TENX) price momentum. RSI 9-day as of the close on 23 August was 61.94%, suggesting the stock is Neutral, with historical volatility in this time frame at 121.29%.
As of today, TENX’s price is $0.3845 +15.97% or $0.0527 from its 5-day moving average. TENX is currently trading +19.78% higher than its 20-day SMA and -17.70% lower than its 100-day SMA. However, the stock’s current price level is +11.84% above the SMA50 and -79.88% below the SMA200.
The stochastic %K and %D were 68.04% and 70.96%, respectively, and the average true range (ATR) was 0.0402. With the 14-day stochastic at 68.76% and the average true range at 0.0361, the RSI (14) stands at 60.96%. The stock has reached 0.0296 on the 9-day MACD Oscillator while the 14-day reading was at 0.0489.
Analyst Ratings
Ladenburg Thalmann upgraded Tenax Therapeutics Inc. (NASDAQ: TENX) to a a Buy rating in its most recent analyst report. Previously, the stock was rated as a Neutral. The consensus rating for Tenax Therapeutics Inc. (TENX) among analysts is Buy. According to current brokerage recommendations, 0 brokerage firms advise that investors sell TENX, while 0 suggest investors hold. There are 0 analysts who rate the stock as underweight. The stock is rated overweight by 0 analysts, while 1 others rate it as a “buy”.
What is TENX’s price target for the next 12 months?
Analysts predict a range of price targets between $5.00 and $6.00, with a median target of $5.50. Taking a look at these predictions, the average price target given by analysts for Tenax Therapeutics Inc. (TENX) stock is $5.50.
